Used primarily in research settings for its anxiolytic and anticonvulsant properties, demonstrating potential as a treatment for anxiety disorders and epilepsy. It acts selectively on benzodiazepine receptors, particularly those associated with GABA-A receptors, which may lead to fewer sedative and cognitive side effects compared to traditional benzodiazepines. Due to its subtype selectivity, it has been studied for developing safer anxiolytic drugs with lower risk of dependence and tolerance. Not approved for clinical use, but valuable in neuroscience research for understanding GABAergic neurotransmission.